Collagen VI in the Musculoskeletal System

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Collagen VI plays mechanical and cytoprotective roles, influencing cell differentiation and autophagy.
• Mutations in COL6A1, COL6A2, and COL6A3 genes cause Ullrich congenital muscular dystrophy (UCMD), Bethlem myopathy (BM), and myosclerosis myopathy (MM).
• These disorders present with muscle wasting, weakness, joint contractures, and respiratory issues, with no current effective treatments.

Purpose of the Study:

• To review the role of collagen VI in the musculoskeletal system.
• To update on tissue-specific functions of collagen VI, particularly concerning mutations.
• To bridge the knowledge gap between researchers and clinicians managing collagen VI-related myopathies.

Main Methods:

• Literature review focusing on collagen VI functions.
• Analysis of studies on animal models with collagen VI mutations.
• Examination of patient-derived samples to understand disease mechanisms.

Main Results:

• Collagen VI is crucial for mechanical integrity and cellular protection against apoptosis and oxidative stress.
• Dysregulation of collagen VI impacts cell differentiation and autophagy, promoting tumor growth.
• Studies reveal diverse tissue-specific effects of collagen VI mutations, extending beyond muscle tissue.

Conclusions:

• Collagen VI mutations lead to a spectrum of congenital muscular disorders with significant clinical manifestations.
• Further research into tissue-specific functions is essential for understanding the full impact of collagen VI mutations.
• Bridging the gap between scientific findings and clinical practice is critical for managing collagen VI-related myopathies.